FOURIER OLE (Ph 4)
Research payments
$40,233,194
Through program year 2020, $40,233,194 in research payments was reported against FOURIER OLE (Ph 4), across 1,289 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $17,143,191 | 704 |
| 2019 | Research | $23,090,003 | 585 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Robert Rosenson New York, NY Named on 16 payments
- Howard Sherman Biddeford, ME Named on 14 payments
- Alan Wiseman Bangor, ME Named on 14 payments
- Sunny Srivastava Haverhill, MA Named on 14 payments
- Brien Pierpont St Petersburg, FL Named on 14 payments
- Elmer Stout Mooresville, NC Named on 14 payments
- Steven Hearne Salisbury, MD Named on 14 payments
- Kenneth Hershon New Hyde Park, NY Named on 12 payments
- Amit Shah Indian Land, SC Named on 12 payments
- Otis Barnum Natchitoches, LA Named on 12 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.